Transitioning to Highly Effective Therapies for the Treatment of Chronic Hepatitis C Virus Infection: A Policy Statement and Implementation Guideline
Chronic hepatitis C virus (HCV) infection increases all-cause mortality, rates of cirrhosis, hepatocellular carcinoma, liver transplantation and overall health care utilization. Morbidity and mortality disproportionately affect individuals born between 1945 and 1975. The recent development of well-t...
Saved in:
Main Authors: | Daniel J Smyth, Duncan Webster, Lisa Barrett, Mark MacMillan, Lisa McKnight, Frank Schweiger |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2014/109046 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatitis D Virus Status Among People With Hepatitis B Virus Infection: A Disconnect Between Guidelines and Practice
by: Kathryn Jack, et al.
Published: (2024-01-01) -
Guidelines for Writing Quality Impact Statements for Workload and Marketing
by: Amy Harder, et al.
Published: (2016-02-01) -
Guidelines for Writing Quality Impact Statements for Workload and Marketing
by: Amy Harder, et al.
Published: (2016-02-01) -
Statement of the Fourth Bologna Policy Forum
by: Editorial Article
Published: (2016-12-01) -
Lipids in parenteral nutrition – expert consensus statements: Translating guidelines into clinical practice
by: Robert G. Martindale, et al.
Published: (2025-04-01)